🇺🇸 FDA
Patent

US 10279029

Immunogenic compositions and uses thereof

granted A61KA61K2039/543A61K2039/55555

Quick answer

US patent 10279029 (Immunogenic compositions and uses thereof) held by The Board of Regents of the University of Texas System expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/543, A61K2039/55555, A61K39/12, A61K39/39